About the board
  - Members of the board
- The secretariat
Norwegian regulation
Norsk
   
   
   
   
The Norwegian Biotechnology Advisory Board
Rosenkrantz' gt. 11,
PO Box 522 Sentrum,
NO-0105 OSLO, Norway
Ph. +47 24 15 60 20
Fax. +47 24 15 60 29
bion[at]bion.no

Biotechnology regulation in Norway

Acts concerning biotechnology

There are two main acts regulating the use of biotechnology in Norway:

  • Act of 5 December 2003 No. 100 relating to the application of biotechnology in human medicine, etc.
  • The Act relating to the production and use of genetically modified organisms (Gene Technology Act).

Other relevant acts are:

  • The Act relating to transplantation, hospital autopsies and the donation of bodies etc.
  • The Act concerning Termination of Pregnancy
  • The Act on personal health data filing systems and the processing of personal health data
  • The Act relating to the processing of personal data
  • The Patents Act
  • The Act concerning the welfare of aminals.

English translations of Norwegian legislations:

  • Biotechnoology Act of 5 December 2003 No. 100 (Official translation)
  • Gene Technology Act ((1993)(official translation))

    • Administration

    The Act relating to the application of biotechnology in medicine is administered by the Ministry of Health and Social Affairs, and medical use of biotechnology is supervised by The Norwegian Board of Health.

    The Act relating to the production and use of genetically modified organisms is administered by both the Ministry of Health and Social Affairs and the Ministry of Environment. Contained use of GMOs is administered by the Ministry of Health and Social Affairs and the National Insitute of Public Health, whereas deliberate release og GMOs is administered by the Ministry of Environment and the Directorate for Nature Management.